Federal Register of Legislation - Australian Government

Primary content

PB 12 of 2014 Arrangements as made
This instrument amends the National Health (Efficient Funding of Chemotherapy) Special Arrangement 2011 (No. PB 79 of 2011) to remove 16 listed brands for the listed drugs ‘Carboplatin’, ‘Cisplatin’, ‘Epirubicin’, ‘Fludarabine’, ‘Gemcitabine’, ‘Irinotecan’, ‘Mitozantrone’, ‘Oxaliplatin’ and ‘Paclitaxel’.
Administered by: Health
Registered 26 Feb 2014
Tabling HistoryDate
Tabled HR04-Mar-2014
Tabled Senate04-Mar-2014
Date of repeal 02 Mar 2014
Repealed by Division 1 of Part 5A of the Legislative Instruments Act 2003
Help with file formats Help with file formats
Legislative Instrument
F2014L00191 : Authoritative PDF Document : 0.4MB Primary Document Icon F2014L00191 : ZIP Document : 74KB
5 pages

Explanatory Statement
F2014L00191ES : PDF Document : 0.4MB Primary Document Icon F2014L00191ES : ZIP Document : 35KB
5 pages